AXA Investment Managers’s AbbVie ABBV Stock Holding History

AXA Investment Managers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$220M	Buy	+948,621	New	+$193M	0.59%	28

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AXA Investment Managers's ABBV Position: Q3 2025 in Review

AXA Investment Managers opened a new position in AbbVie (ABBV) in Q3 2025: 948,621 shares worth $220M. The stake represents 0.59% of the portfolio and ranks #28 among its holdings.

3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

AXA Investment Managers held 948,621 shares of AbbVie worth $220M as of Q3 2025.
AbbVie was a new AXA Investment Managers position in Q3 2025.
AbbVie made up 0.59% of AXA Investment Managers's portfolio in Q3 2025, its #28 holding.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.